Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 47.11
-0.94 (-1.96%)
Jun 2, 2026, 3:04 PM CST
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 6.12 billion as of June 2, 2026. Its market cap has decreased by -12.11% in one year.
Market Cap
6.12B
Enterprise Value
5.10B
Revenue
1.20B
Ranking
n/a
PE Ratio
27.02
Stock Price
47.11
Market Cap Chart
Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 6.12B, an increase of 0.69%. That is a compound annual growth rate of 0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 6.12B | -34.80% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 6.78B |
| Xiangxue Pharmaceutical | 6.56B |
| Jiangsu Aidea Pharmaceutical Group | 6.53B |
| Suzhou Fengbei Biotech Stock | 6.32B |
| Wuhan Keqian Biology Co.,Ltd | 6.10B |
| Shanghai OPM Biosciences | 6.07B |
| Anhui Huaheng Biotechnology | 5.85B |
| Novogene | 5.73B |